Immunological profile of Fanconi anemia: A multicentric retrospective analysis of 61 patients

American Journal of Hematology

Volumn 88, Issue 6, 2013, Pages 472-476

  Korthof, Elisabeth T ^a   Svahn, Johanna ^b   de Latour, Regis Peffault ^c   Terranova, Paola ^b   Moins Teisserenc, Helene ^c   Socié, Gérard ^c   Soulier, Jean ^c   Kok, Marleen ^a   Bredius, Robbert G M ^a   van Tol, Maarten ^a   Jol van der Zijde, Els C M ^a   Pistorio, Angela ^b   Corsolini, Fabio ^b   Parodi, Alessia ^d   Battaglia, Florinda ^d   Pistoia, Vito ^b   Dufour, Carlo ^b   Cappelli, Enrico ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b G GASLINI INSTITUTE   (Italy)

^c SAINT LOUIS HOSPITAL   (France)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; BONE MARROW DEPRESSION; CHILD; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FANCONI ANEMIA; FEMALE; HELPER CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL MONITORING; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYTOKINES; FANCONI ANEMIA; FEMALE; HUMANS; IMMUNOGLOBULINS; IMMUNOPHENOTYPING; LYMPHOCYTE SUBSETS; MALE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84878208992     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23435     Document Type: Article

References (26)

1. Soulier J. Fanconi anemia. Hematology Am Soc Hematol Educ Program 2011;2011:492-497.
2. Fagerlie SR, Bagby GC. Immune defects in Fanconi anemia. Crit Rev Immunol 2006;26:81-96.
3. Castello G, Gallo C, Napolitano M, et al. Immunological phenotype analysis of patients with Fanconi's anaemia and their family members. Acta Haematol 1998;100:39-43.
4. Myers KC, Bleesing JJ, Davies SM, et al. Impaired immune function in children with Fanconi anaemia. Br J Haematol 2011;154:234-240.
5. Park JW, Pitot HC, Strati K, et al. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer. Cancer Res 2010;70:9959-9968.
6. Holmgren SC, Goren EM, Wood BL, et al. Immune defects in a mouse model of Fanconi anaemia. Br J Haematol 2012;159:246-250.
7. Rosselli F, Sanceau J, Wietzerbin J, et al. Abnormal lymphokine production: A novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6. Hum Genet 1992;89:42-48.
8. Schultz JC, Shahidi NT. Tumor necrosis factor-α overproduction in Fanconi's anemia. Am J Hematol 1993;42:196-201.
9. Dufour C, Corcione A, Svahn J, et al. TNF-α and IFN-γ are overexpressed in the bone marrow of Fanconi anemia patients and TNF-α suppresses erythropoiesis in vitro. Blood 2003;102:2053-2059.
10. Li J, Sejas DP, Zhang X, et al. TNF-α induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells. J Clin Invest 2007;117:3283-3295.
11. Ibáñez A, Río P, Casado JA, et al. Elevated levels of IL-1β in Fanconi anaemia group A patients due to a constitutively active phosphoinositide 3-kinase-Akt pathway are capable of promoting tumour cell proliferation. Biochem J 2009;422:161-170.
12. de Cremoux P, Gluckman E, Podgorniak MP, et al. Decreased IL-1β and TNF-α secretion in long-term bone marrow culture supernatant from Fanconi's anaemia patients. Eur J Haematol 1996;57:202-207.
13. Lecourt S, Vanneaux V, Leblanc T, et al. Bone marrow microenvironment in Fanconi anemia: A prospective functional study in a cohort of Fanconi anemia patients. Stem Cells Dev 2010;19:203-208.
14. Rathbun RK, Faulkner GR, Ostroski MH, et al. Inactivation of the Fanconi anemia group C gene augments interferon-γ-induced apoptotic responses in hematopoietic cells. Blood 1997;90:974-985.
15. Anur P, Yates J, Garbati MR, et al. p38 MAPK inhibition suppresses the TLR-hypersensitive phenotype in FANCC- and FANCA-deficient mononuclear phagocytes. Blood 2012;119:1992-2002.
16. Ceccaldi R, Parmar K, Mouly E, et al. Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell 2012;11:36-49.
17. Shao L, Fujii H, Colmegna I, et al. Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis. J Exp Med 2006;206:1435-1449.
18. + T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells. J Immunol 2008;180:7305-7317.
19. Olas K, Butterweck H, Teschner W, et al. Immunomodulatory properties of human serum immunoglobulin A: Anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells. Clin Exp Immunol 2005;140:478-490.
20. Bijangi-Vishehsaraei K, Saadatzadeh MR, Werne A, et al. Enhanced TNF-α-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1. Blood 2005;106:4124-4130.
21. + T-regulatory cells: Toward therapy for human diseases. Immunol Rev 2008;223:391-421.
22. Armitage RJ, Maliszewski CR, Alderson MR, et al. CD40L: A multi-functional ligand. Semin Immunol 1993;5:401-412.
23. Isufi I, Seetharam M, Zhou L, et al. Transforming growth factor-β signaling in normal and malignant hematopoiesis. J Interferon Cytokine Res 2007;27:543-552.
24. Sargiacomo M, Valtieri M, Gabbianelli M, et al. Pure human hematopoietic progenitors: Direct inhibitory effect of transforming growth factors-β1 and -β2. Ann N Y Acad Sci 1991;628:84-91.
25. Schönbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001;58:4-43.
26. Foy TM, Shepherd DM, Durie FH, et al. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med 1993;178:1567-1575.